Filter
82
Filtered Results: 82
Text search:
Multisystemic
Inflammatory
Syndrome
Featured
Recommendations
20
New Publications
4
Language
Document type
Guidelines
46
Fact sheets
12
Manuals
8
Studies & Reports
6
No document type
5
Training Material
2
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Brazil
10
Germany
5
Russia
4
India
4
Rwanda
2
Syria
2
Nigeria
2
Mozambique
2
Latin America and the Carribbean
2
Middle East and North Africa
2
Western and Central Europe
2
Yemen
2
Colombia
1
Ukraine
1
Sierra Leone
1
Malawi
1
Africa
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
East and Southern Africa
1
Argentina
1
South Africa
1
Uganda
1
South Sudan
1
Liberia
1
Authors & Publishers
Publication Years
Category
COVID-19
30
Guidelines
18
Studies & Reports
3
Pediatrics
2
Policies
2
Women & Child Health
2
Paediatrics
1
Hepatitis
1
Palliative Care
1
NCD
1
Hemorrhagic Fever
1
Clinical Guidelines
1
Capacity Building
1
Palliative Care
1
Respiratory Infections
1
Communicable Diseases
1
HIV & STI
1
TB
1
Toolboxes
Country specific documents
21
Paediatrics
19
Clinical Guidelines
12
Long COVID/ Post-COVID Syndrome
10
Educational Settings
7
Inactivated COVID-19 Vaccines
5
Infection Control General
4
For Parents & Children
4
Immunization Guidelines
4
Biontech/Pfizer Comirnaty
3
Treatment Guidelines
2
Prevention & Preparedness
2
Surveillance & Contact tracing
2
COVID-19
2
Training, others
2
For Migrants & Refugees
2
Scientific & Research Studies
2
Gender Aspects
2
Access & Strategy
2
Moderna
2
Ebola
1
Livestock production
1
Context & Facts, Travel Advice
1
Clinical Aspects
1
For Pregnant Women
1
Prison & Detention
1
Child Protection
1
HIV and COVID-19
1
COVID-19
1
Oxygen Therapy
1
Hospital Readiness/Essential Health Services
1
Vaccine Candidates & Research
1
TB/COVID-19
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Covaxin
1
Research & Pipeline
1
Others
1
Palliative Care
1
Guidelines & Manuals
1
Prevention & Measures
1
Co-Morbidities (except TB)
1
Public Health Administration
1
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen...
The purpose of this pocketbook is to provide clear guidance on current best management practices for VHF across health-care facilities
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,...
Update, 23 de junio de 2022
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
first issued 18 August 2022
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
